BiowaveHOME Neuromodulation Pain Therapy Device

Stimulator, Nerve, Transcutaneous, For Pain Relief

BIOWAVE CORPORATION

The following data is part of a premarket notification filed by Biowave Corporation with the FDA for Biowavehome Neuromodulation Pain Therapy Device.

Pre-market Notification Details

Device IDK152437
510k NumberK152437
Device Name:BiowaveHOME Neuromodulation Pain Therapy Device
ClassificationStimulator, Nerve, Transcutaneous, For Pain Relief
Applicant BIOWAVE CORPORATION 16 KNIGHT STREET Norwalk,  CT  06851
ContactBradford Siff
CorrespondentBradford Siff
BIOWAVE CORPORATION 16 KNIGHT STREET Norwalk,  CT  06851
Product CodeGZJ  
CFR Regulation Number882.5890 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2015-08-27
Decision Date2015-09-25
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00859911006072 K152437 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.